反応式
[CH2:1]([OH:4])[CH:2]=[CH2:3].F[C:6]1[CH:7]=[C:8]([CH3:15])[CH:9]=[CH:10][C:11]=1[N+:12]([O-:14])=[O:13].[CH3:16][C:17]1[CH:23]=[CH:22][C:20]([NH2:21])=[C:19]([O:24][CH2:25][CH:26]=[CH2:27])[CH:18]=1.CC1C=CC(N)=[C:31]([O:36]CC(C)C)C=1.[NH2:41][C:42]1[S:43][CH:44]=[CH:45][N:46]=1>>[CH2:1]([O:4][C:6]1[CH:7]=[C:8]([CH3:15])[CH:9]=[CH:10][C:11]=1[N+:12]([O-:14])=[O:13])[CH:2]=[CH2:3].[CH2:25]([O:24][C:19]1[CH:18]=[C:17]([CH3:16])[CH:23]=[CH:22][C:20]=1[NH:21][C:31]([NH:41][C:42]1[S:43][CH:44]=[CH:45][N:46]=1)=[O:36])[CH:26]=[CH2:27]参加物
7
反応物 5
生成物 2
実験手順
3-Allyloxy-4-nitrotoluene (0.67 g, 70%) was prepared from allyl alcohol and 3-fluoro-4-nitrotoluene (0.77 g, 5.0 mmol) following the general procedure G. This was reduced to 4-methyl-2-(allyloxy)aniline (0.40 g, 70%) following general procedure B. 1-(2-Allyloxy-4-methyl-phenyl)-3-thiazol-2-yl-urea (196 mg, 68%) was prepared from 4-methyl-2-(2-methylpropoxy)aniline (163 mg, 1.0 mmol) and 2-aminothiazole (100 mg, 1.0 mmol) following the general procedure D.
出典と根拠
- ORDレコード
- ord-155ccbdc017b437ab321017e95ef4026
- 出典データセット
- uspto-grants-2015_09
- 特許番号
- USRE045670E1
関連ノート
読み込み中…